Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D4OU6H
|
|||
Drug Name |
Rivo-cel
|
|||
Synonyms |
BPX-501
Click to Show/Hide
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Acute myeloid leukaemia [ICD-11: 2A60; ICD-9: 205] | Phase 2/3 | [1] | |
Myelodysplastic syndrome [ICD-11: 2A37; ICD-9: 238.7] | Phase 2/3 | [1] | ||
Company |
Bellicum Pharmaceuticals
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03699475) Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS (THRIVE). U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.